ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.

@article{Steg2012ESCGF,
  title={ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.},
  author={Ph. Gabriel Steg and Stefan K James and Dan Atar and Luigi P Badano and Carina Bl{\"o}mstrom-Lundqvist and Michael A. Borger and Carlo Di Mario and Kenneth Dickstein and Gr{\'e}gory Ducrocq and Francisco Fern{\'a}ndez‐Avil{\'e}s and Anthony H Gershlick and Pantaleo Giannuzzi and Sigrun Halvorsen and Kurt Huber and Peter Juni and Adnan Kastrati and Juhani Knuuti and Mattie J. Lenzen and Kenneth W. Mahaffey and Marco Valgimigli and Arnoud W.J. van ’t Hof and Petr Widimsky and Doron Zahger},
  journal={European heart journal},
  year={2012},
  volume={33 20},
  pages={
          2569-619
        }
}
ACE : angiotensin-converting enzyme ACS : acute coronary syndrome ADP : adenosine diphosphate AF : atrial fibrillation AMI : acute myocardial infarction AV : atrioventricular AIDA-4 : Abciximab Intracoronary vs. intravenously Drug Application APACHE II : Acute Physiology Aand Chronic 
View on PubMed
academic.oup.com
7,395 Citations
Highly Influential Citations
328
Background Citations
1,025
Methods Citations
504
Results Citations
71

7,395 Citations

Comments on the ESC Guidelines for the Management of Acute Myocardial Infarction in Patients Presenting With ST-Segment Elevation.

Aborted myocardial infarction in patients with ST ‑segment elevation myocardial infarction treated with mechanical reperfusion

This study aimed to identify patients with abMI and compare them with the remaining patients with elevation myocardial infarction (STEMI) and find out if these patients have the same underlying cause of death.

Strategies to improve outcome in patients with ST elevation myocardial infarction treated with primary PCI

A single punctured atherosclerotic plaque with overlying thrombosis leads to ischemia and progressively to the death of the myocardial cells, leading toSTEMI, in patients withSTEMI-positive hearts.

Optimal Timing of Coronary Intervention in Non-Culprit Lesion in ST Elevation Myocardial Infarction with Multi-Vessel Disease

► See the article “One-Year Clinical Outcomes between Single- versus Multi-Staged PCI for ST Elevation Myocardial Infarction with Multi-Vessel Coronary Artery Disease: from Korea Acute Myocardial…

2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: comments from the Dutch ACS working group

The most important changes in recommendations in the 2017 ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation are discussed, relevant for both the general and interventional cardiologist.

ST-segment elevation myocardial infarction: Historical perspective and new horizons

The role of angiography, pharmacotherapy, thrombus aspiration, management of multi-vessel disease, mechanical complications and cardiogenic shock and the quest for myocardial salvage are discussed.

Improving the secondary prevention of ST-elevation myocardial infarction.

Secondary prevention medications following ST-elevation myocardial infarction (STEMI) have been established with NICE and European Society of Cardiology guidelines.[1,2][1] In practice, while most…

Late Percutaneous Coronary Intervention Prevents Left Ventricular Remodeling and Improves Clinical Outcomes in Patients With ST‐Elevation Myocardial Infarction

The optimal strategy for treating late presenters of ST‐elevation myocardial infarction (STEMI) remains uncertain and further research is needed to establish a single treatment strategy.

ST-Elevation Myocardial Infarction

Acute ST elevation myocardial infarction (STEMI) is the leading cause of death in the United States and excellent societal guideline recommendations exist for STEMI care.

2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines.

Preamble e346 1. Overview of Acs e349 2. Initial Evaluation and Management e350 3. Early Hospital Care e359
...

References

SHOWING 1-10 OF 399 REFERENCES

ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

Indications for fibrinolytic therapy in suspected acute myocardial infarction : collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

It is shown that fibrinolytic therapy can reduce mortality in patients with suspected acute myocardial infarction (AMI) and the indications for, and contraindications to, this therapy.

Right ventricular dysfunction is an independent predictor for mortality in ST‐elevation myocardial infarction patients presenting with cardiogenic shock on admission

Right ventricular dysfunction is an established independent predictor for adverse prognosis in STEMI patients without CS and the prognostic value of RV dysfunction on admission inSTEMI patients presenting in CS is determined.

Incidence and Predictors of Bleeding After Contemporary Thrombolytic Therapy for Myocardial Infarction

A small number of patients with a history of bleeding and known risk factors for bleeding have responded to thrombolytic therapy, and these results suggest that this therapy may be beneficial in patients with high levels of bleeding.

Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators

There remains a substantial subgroup of patients who manifest clinical evidence of heart failure despite the first two of these treatments, despite survival after acute myocardial infarction being enhanced by treatment with thrombolytic agents, aspirin, and Beta -adrenoceptor blockade.

Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at 'moderate risk' [CHADS2 score=1]: simplifying stroke risk assessment and thromboprophylaxis in real-life clinical practice.

  • G. Lip
  • Medicine, Psychology
    Thrombosis and haemostasis
  • 2010
Anticoagulation therapy and the risk of stroke in patients with atrial fibrillation at ‘moderate risk’ [CHADS2 score=1]: Simplifying stroke risk assessment and thromboprophylaxis in real-life…

Ventricular Fibrillation and Polymorphic Ventricular Tachycardia with Critical Coronary Artery Stenosis:

The experience in patients with one or more episodes of sudden death associated with documented ventricular fibrillation or polymorphic ventricular tachycardia and severe operable coronary artery disease who underwent defibrillator implant at the time of bypass surgery is presented.

Universal definition of myocardial infarction.

The document is based on the Fourth Universal Definition of Myocardial Infarction, developed jointly by experts from the European Society of Cardiology (ETC) / American College of Cardiology (ACC) /…

Non-culprit coronary artery percutaneous coronary intervention during acute ST-segment elevation myocardial infarction: insights from the APEX-AMI trial.

Non-culprit coronary interventions were performed at the time of primary PCI in 10% of MVD patients and were significantly associated with increased mortality, which supports current guideline recommendations discouraging the performance of such procedures in stable primary PCI patients.

Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary--a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) a

An executive summary highlights the main recommendations from the consensus document, which comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline.
...